Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inopro is a French medical technology company specializing in the design and manufacture of innovative delivery systems for inhaled nitric oxide (iNO) therapy. The company provides high-precision gas dosing and monitoring solutions, such as the Ino-Dose and Ino-Check systems, which are used in critical care settings to treat conditions like persistent pulmonary hypertension in newborns and acute respiratory distress syndrome. In addition to its own product line, Inopro operates as a specialized CDMO and OEM partner, offering research, development, and industrialization services for medical gas applications. The company is ISO 13485 certified and focuses on improving the safety and efficacy of respiratory gas treatments through advanced engineering and regulatory expertise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inopro.